Related Experiment Video
Updated: Sep 14, 2025

A Multimodal Imaging Framework to Advance Phenotyping of Living Label-free Breast Cancer Cells
Published on: August 22, 2025
Integrating multimodal cancer data using deep latent variable path modelling
Alex Ing1, Alvaro Andrades1, Marco Raffaele Cosenza1
1Genome Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany.
None:
Cancers are commonly characterized by a complex pathology encompassing genetic, microscopic and macroscopic features, which can be probed individually using imaging and omics technologies. Integrating these data to obtain a full understanding of pathology remains challenging. We introduce a method called deep latent variable path modelling, which combines the representational power of deep learning with the capacity of path modelling to identify relationships between interacting elements in a complex system. To evaluate the capabilities of deep latent variable path modelling, we initially trained a model to map dependencies between single-nucleotide variant, methylation profiles, microRNA sequencing, RNA sequencing and histological data using breast cancer data from The Cancer Genome Atlas. This method exhibited superior performance in mapping associations between data types compared with classical path modelling. We additionally performed successful applications of the model to stratify single-cell data, identify synthetic lethal interactions using CRISPR-Cas9 screens derived from cell lines and detect histologic-transcriptional associations using spatial transcriptomic data. Results from each of these data types can then be understood with reference to the same holistic model of illness.
More Related Videos
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
Related Concept Videos
Cancer Survival Analysis
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Multicompartment Models: Overview
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...